Trial design
The study was open-label, quasi-experimental, prospective and unicentric study developed in a PED of a third-level Spanish hospital which receives 58,000 emergencies annually. The study took place between June 2020 and February 2021. The trial was approved by the hospital’s Institutional Review Board.